85 PHASE ANGLE AND LONG-TERM OUTCOME 5 independent predictor of 1-year mortality (OR: 1.81; CI: 1.09-2.97; p = 0.02), in addition to the presence of malignancy (OR: 2.30; CI: 1.31-4.02; p = 0.004) and APACHE III score (OR: 1.03; CI: 1.02-1.04; p < 0.001) (Table 2). Using the previously identified optimal cut-off PhA value, a Kaplan Meier curve for 1-year survival of the group with low PhA and the high PhA group indicated all-cause 1-year mortality was significantly higher in patients with a low PhA (p < 0.001, Figure 2). Using a Cox-proportional hazard model corrected for APACHE III score, PhA remained a significant predictor of survival (Hazard ratio: 1.850, CI: 1.269-2.699, p = 0.001). Table 2. Univariate and multivariate analysis of 1-year mortality Risk factor Univariate analysis Multivariate analysis OR (95% CI) p-value OR (95% CI) p-value Low PhA (<4.6 degrees) 3.242 (2.180-4.820) <0.001 1.81 (1.09-2.97) 0.020 APACHE III 1.045 (1.037-1.053) <0.001 1.03 (1.02-1.04) <0.001 Admission type: acute 5.251 (3,425-8,052) <0.001 Presence of sepsis 3.799 (2.234-6.460) <0.001 Presence of malignancy 3.361 (2.131-5.300) <0.001 2.30 (1.31-4.02) 0.004 CRP at admission 1.003 (1.001-1.005) 0.002 Serum albumin at admission 0.951 (0.920-0.983) 0.003 OR, odds ratio; CI, confidence interval
RkJQdWJsaXNoZXIy MjY0ODMw